GB512145A - The preparation of new therapeutically useful heterocyclic compounds - Google Patents

The preparation of new therapeutically useful heterocyclic compounds

Info

Publication number
GB512145A
GB512145A GB3292537A GB3292537A GB512145A GB 512145 A GB512145 A GB 512145A GB 3292537 A GB3292537 A GB 3292537A GB 3292537 A GB3292537 A GB 3292537A GB 512145 A GB512145 A GB 512145A
Authority
GB
United Kingdom
Prior art keywords
chloride
aminopyridine
pyridine
aminobenzenesulphonamido
followed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB3292537A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
May and Baker Ltd
Original Assignee
May and Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May and Baker Ltd filed Critical May and Baker Ltd
Priority to GB3292537A priority Critical patent/GB512145A/en
Publication of GB512145A publication Critical patent/GB512145A/en
Priority to CY6041A priority patent/CY60A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/76—Nitrogen atoms to which a second hetero atom is attached

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)

Abstract

512,145. Sulphonamide compounds. MAY & BAKER, Ltd., EWINS, A. J., and PHILLIPS, M. A. Nov. 29, 1937, Nos. 32925/37, 14197/38 and 17042/38. [Class 2 (iii)] p-Aminobenzenesulphonamido derivatives of the pyridine, quinoline and isoquinoline series, which possess therapeutic properties, are prepared by (1) reacting a benzenesulphonyl halide containing an acylamino, nitro,' azo or halogen substituent in the p-position with a pyridine, quinoline or isoquinoline compound containing an amino substituent having at least one reactive hydrogen ; the acylamino group in the product may then be hydrolyzed, the nitro and azo groups are reduced and the halogen atom is converted into an amino or substituted group by treatment with ammonia or a primary or secondary amine; (2) reacting a benzenesulphonamide containing an acylamino, nitro, azo or halogen substituent in the p-position with a pyridine, quinoline or isoquinoline compound containing a reactive halogen substituent, and the resulting compound then treated as in (1). The products, in so far as they contain a reactive hydrogen, may be treated with an acyl, alkyl, aryl or aralkyl halide or an alkyl sulphate. Examples are given of the condensation of (1) p-acetylaminobenzenesulphonyl chloride with 2-aminopyridine, 6-aminoquinaldine, 5-amino-8- methoxyquinoline, 2-hydroxy-4-methyl-7- aminoquinoline, 2-aminopyridine-3-carboxylic acid, 2-amino-6-methylpyridine, 6-aminoquinoline, 4-aminopyridine, 1-aminoisoquinoline, 5-iodo-2-aminopyridine and 2- methylaminopyridine, followed in each case by treatment with caustic soda solution to split off the acetyl group ; (2) p-acetylaminobenzenesulphonyl chloride with 2-aminopyridine; (3) p-acetylaminobenzenesulphonyl chloride (2 mols.) with 2:6-diaminopyridine (1 mol.), followed by hydrolysis with caustic soda ; (4) p-nitrobenzenesulphonyl chloride with 2-aminopyridine and reduction of the product with ferrous hydroxide ; (5) p-nitrobenzenesulphonic acid anhydride with 2-aminopyridine and 6-aminoquinine, aldand subsequent reduction of the nitro group using ferrous hydroxide ; (6) p<1>-diethylaminoazobenzene-p-sulphonyl chloride with 2-aminopyridine, followed by reduction with sodium hydrosulphite to give 2-(p-aminobenzenesulphonamido)-pyridine ; (7) p-chlorobenzenesulphonyl chloride. with 2-aminopyridine and heating the 2-(p-chlorobenzenesulphonamido)- pyridine in an autoclave with aqueous ammonia ; (8) p-acetylaminobenzenesulphonamide with 2-bromopyridine and 2-chloroquinoline in the presence of copper powder, followed by alkaline hydrolysis ; (9) p-acetylaminobenzenesulphonamide with 5-nitro-2-chloropyridine; (10) p-acetylaminobenzenesulphonmethylamide, prepared from the sulphonyl chloride and methylamine, with 2-bromopyridine in the presence of copper powder, and hydrolyzing the product; (11) 2-(p-chloro or bromo-benzenesulphonamido )-pyridine, prepared from p-chloro or bromobenzenesulphonyl chloride and 2- aminopyridine, with methylamine or dimethylamine in an autoclave in the presence of cuprous chloride ; (12) p-acetylbenzylaminobenzenesulphonyl chloride (see Specification 483,945) with 2-aminopyridine, followed by hydrolysis with caustic soda solution ; (13) p-acetylaminobenzenesulphonyl chloride with phenyl 2-aminopyridine-5-sulphonate and hydrolysis with caustic soda solution to give 2 - (p - aminobenzenesulphonamido) - pyridine - 5 - sulphonic acid ; (14) 2 : 4-dinitrodiphenylamine-41-sulphonyl chloride with 2-aminopyridine. Further examples describe the treatment of (15) 2-(p-aminobenzenesulphonamido)-pyridine with p-nitrobenzoyl chloride to give the p<1>-nitrobenzoylamino compound ; (16) 2-(p-amino- and dimethylamino-benzenesulphonamido)-pyridines with dimethyl sulphate to form the corresponding sulphonmethylamido products; (17) 2-(p-aminobenzenesulphonamido)-pyridine with benzyl chloride to yield the sulphonbenzylamido body; (18) 2-(p-aminobenzenesulphonmethylamido)- pyridine with acetic anhydride to form the p-acetylamino compound. p-Nitrobenzenesulphonic acid anhydride is prepared by the action of thionyl chloride on p-nitrobenzenesulphonic acid dihydrate. 2 : 4 - Dinitrodiphenylamine - 4<1> - sulphonyl chloride is obtained by reacting the sodium salt of the. sulphonic acid with phosphorus pentachloride. p<1> - Diethylaminoazobenzene - p - sulphonyl chloride is prepared by the action of phosphorus pentachloride on the sodium salt of the sulphonic acid.
GB3292537A 1937-11-29 1937-11-29 The preparation of new therapeutically useful heterocyclic compounds Expired GB512145A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB3292537A GB512145A (en) 1937-11-29 1937-11-29 The preparation of new therapeutically useful heterocyclic compounds
CY6041A CY60A (en) 1937-11-29 1941-05-28 The preparation of new therapeutically useful heterocyclic compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB3292537A GB512145A (en) 1937-11-29 1937-11-29 The preparation of new therapeutically useful heterocyclic compounds

Publications (1)

Publication Number Publication Date
GB512145A true GB512145A (en) 1939-08-30

Family

ID=10346028

Family Applications (1)

Application Number Title Priority Date Filing Date
GB3292537A Expired GB512145A (en) 1937-11-29 1937-11-29 The preparation of new therapeutically useful heterocyclic compounds

Country Status (2)

Country Link
CY (1) CY60A (en)
GB (1) GB512145A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2420703A (en) * 1941-02-05 1947-05-20 Mead Johnson & Co 2-sulfanilamidopyrazine
US2430439A (en) * 1940-03-01 1947-11-04 American Cyanamid Co Sulfonamido pyrimidines
DE857054C (en) * 1942-08-16 1952-11-27 Boehringer & Soehne Gmbh Process for the production of sulfonamide compounds of cinchona alkaloids
DE933340C (en) * 1939-11-24 1955-09-22 Schering Ag Process for the preparation of therapeutically useful agents of the p-aminobenzenesulfonamide series

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE933340C (en) * 1939-11-24 1955-09-22 Schering Ag Process for the preparation of therapeutically useful agents of the p-aminobenzenesulfonamide series
US2430439A (en) * 1940-03-01 1947-11-04 American Cyanamid Co Sulfonamido pyrimidines
US2420703A (en) * 1941-02-05 1947-05-20 Mead Johnson & Co 2-sulfanilamidopyrazine
DE857054C (en) * 1942-08-16 1952-11-27 Boehringer & Soehne Gmbh Process for the production of sulfonamide compounds of cinchona alkaloids

Also Published As

Publication number Publication date
CY60A (en) 1941-05-28

Similar Documents

Publication Publication Date Title
US2410793A (en) Sulfonamido pyrimidines
US2259222A (en) Preparation of sulphanilamide derivatives
US1860286A (en) Basic ethers of aryl-quinolines
GB577843A (en) Biguanide derivatives
US2476655A (en) Derivatives of sulfonic acid amides and a method of preparing the same
US2275354A (en) Preparation of new therapeutically useful heterocyclic compounds
GB1006139A (en) Improvements in and relating to sulphobetaines
US2202933A (en) Sulphanilamido-aminopyridines and process for producing the same
US2335221A (en) Therapeutically useful heterocyclic compounds
US1181485A (en) Oxyphenylquinolin-dicarboxylic acid and process of making same.
US2148910A (en) Azo compounds
US2312032A (en) Preparation of new therapeutically useful heterocyclic compounds
US2409291A (en) Chemotherapeutic sulfanilamide derivatives
US2353449A (en) Preparation of new therapeutically useful heterocyclic compounds
GB1047418A (en)
GB753735A (en) Process for the manufacture of n-alkyl anthranilic acid-sulphonic acids and of derivatives of these sulphonic acids
GB703484A (en) New quinolinium salts
US2916489A (en) Sultames
GB542319A (en) Improvements relating to the production of sulphonamide compounds
GB738676A (en) New 2-substituted benzthiazole compounds and silver halide emulsions containing them
GB1082466A (en) 2-benzamidophenylalkanoic acid derivatives and their preparation
Burton et al. 10. The synthesis of some aryl pyridyl sulphones (arylsulphonylpyridines)
GB516288A (en) The manufacture of new heterocyclic compounds
GB638513A (en) Process of preparing penicillamine and its derivatives
JPH0119382B2 (en)